Antifibrinolytic Therapy in Pediatric Congenital Heart Surgery
Fig. 40.1 Mechanism of action for tranexamic acid (TXA), e-aminocaproic acid (EACA), and aprotinin during fibrinolysis (t-PA tissue-type-plasminogen activator, u-PA urokinase type-plasminogen activator, PAI plasminogen activator inhibitor, FDP fibrin degradation…